Drug intelligence / Profile preview

FOL500

Development stage: Preclinical
Lead developer: Follicle Pharma
Modality: Nanoparticles → Drug Delivery Systems, Small Molecules
Administration: Topical

Overview

FOL500 is a cosmetic product candidate developed by Follicle Pharma, featuring folic acid encapsulated in a proprietary topical nano-emulsion. This formulation is designed using the company's specialized delivery platform to target hair follicles effectively. While Follicle Pharma's lead program, FOL100, is aimed at treating androgenetic alopecia, FOL500 is intended for broader cosmetic applications. The nano-emulsion technology enhances the stability and localized delivery of folic acid, a B-vitamin essential for DNA synthesis and cellular repair, thereby supporting the health and maintenance of hair and skin.

Other names: folic acid topical nano-emulsion

Targets

FOLR1 (FRα)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on FOL500.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FOL500.

Explore the full profile